TW213901B - - Google Patents

Download PDF

Info

Publication number
TW213901B
TW213901B TW081110044A TW81110044A TW213901B TW 213901 B TW213901 B TW 213901B TW 081110044 A TW081110044 A TW 081110044A TW 81110044 A TW81110044 A TW 81110044A TW 213901 B TW213901 B TW 213901B
Authority
TW
Taiwan
Prior art keywords
phenyl
gas
page
butyl
cns
Prior art date
Application number
TW081110044A
Other languages
English (en)
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW213901B publication Critical patent/TW213901B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW081110044A 1992-01-27 1992-12-15 TW213901B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
TW213901B true TW213901B (de) 1993-10-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081110044A TW213901B (de) 1992-01-27 1992-12-15

Country Status (19)

Country Link
EP (1) EP0625145A1 (de)
JP (1) JPH07503465A (de)
KR (1) KR950700257A (de)
CN (1) CN1074903A (de)
AU (1) AU3276193A (de)
BR (1) BR9207071A (de)
CA (1) CA2117367A1 (de)
CZ (1) CZ391092A3 (de)
FI (1) FI943513A0 (de)
HU (1) HUT70496A (de)
IL (1) IL104472A0 (de)
MX (1) MX9300409A (de)
NO (1) NO942775L (de)
NZ (1) NZ245759A (de)
RU (1) RU94038063A (de)
TW (1) TW213901B (de)
WO (1) WO1993015059A1 (de)
YU (1) YU4393A (de)
ZA (1) ZA93582B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
AU6686694A (en) * 1993-07-26 1995-02-20 Pfizer Inc. Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
DK0730581T3 (da) * 1993-11-22 2001-11-26 Merck & Co Inc 3-acylaminobezazepiner
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
FI971378L (fi) * 1994-10-04 1997-04-03 Pfizer Menetelmiä ja välituotteita 3-aminobentso(b)-atsepinonien valmistusta varten
JPH10511928A (ja) 1994-10-14 1998-11-17 グラクソ、ウェルカム、ソシエタ、ペル、アツィオーニ 睡眠障害の治療のためのｃｃｋ−ｂレセプター拮抗薬の使用
DE10153348A1 (de) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
KR20080031281A (ko) * 2005-06-16 2008-04-08 노파르티스 아게 락탐을 함유하는 ｈｃｖ 억제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (de) * 1984-06-26 1988-10-26 Merck & Co. Inc. Kondensierte Benzo-Laktame und deren pharmazeutische Zusammensetzungen
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (de) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolaktam-Verbindungen und deren pharmazeutische Verwendungen
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
AU3276193A (en) 1993-09-01
FI943513A7 (fi) 1994-07-26
NO942775L (no) 1994-09-20
JPH07503465A (ja) 1995-04-13
CA2117367A1 (en) 1993-08-05
EP0625145A1 (de) 1994-11-23
IL104472A0 (en) 1993-05-13
HUT70496A (en) 1995-10-30
FI943513L (fi) 1994-07-26
YU4393A (sr) 1996-01-09
BR9207071A (pt) 1995-12-05
MX9300409A (es) 1993-07-01
WO1993015059A1 (en) 1993-08-05
HU9402195D0 (en) 1994-09-28
NO942775D0 (no) 1994-07-26
CN1074903A (zh) 1993-08-04
RU94038063A (ru) 1996-05-27
KR950700257A (ko) 1995-01-16
CZ391092A3 (en) 1994-01-19
NZ245759A (en) 1997-06-24
FI943513A0 (fi) 1994-07-26
ZA93582B (en) 1994-07-27

Similar Documents

Publication Publication Date Title
US7553861B2 (en) Dipeptidyl peptidase-IV inhibitors
JP6843114B2 (ja) ムスカリン作動薬
JP6313416B2 (ja) Ｉｄｏ阻害剤
TW202432B (de)
JPH07504908A (ja) ベンゾジアゼピン誘導体，該誘導体を含有する組成物及び治療におけるその使用
CZ283950B6 (cs) 1,5-Benzodiazepinové deriváty a jejich použití v medicíně
PL172069B1 (pl) Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
JPH09503231A (ja) 新規のフェニルアルキルアミノアルコールカルバメートとその製造方法
JPH05345767A (ja) ベンゾジアゼピン誘導体、それを含有する組成物、及び治療に於ける使用
TWI235151B (en) Lactam compound
TW438777B (en) Compounds useful as NK1 and/or NK2 anagonists and the pharmaceutical composition and preparation process thereof
US6828324B2 (en) Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
JP2001504454A (ja) ベンゾジアゼピン誘導体
TW209870B (de)
JPH0348695A (ja) ペプチド誘導体
JPH03204866A (ja) オキシトシン拮抗薬としての３―置換―１，４―ベンゾジアゼピン類
KR101880841B1 (ko) 미량 아민 결합 수용체 1(taar1) 조절제로서 5-옥사-2-아자바이사이클로[2.2.2]옥탄-4-일 및 5-옥사-2-아자바이사이클로[2.2.1]헵탄-4-일 유도체
WO1997016425A1 (en) Novel inhibitors of peptide binding to mhc class ii proteins
US20080306044A1 (en) Spirobenzoazepanes as vasopressin antagonists
IL101514A (en) Benzodiazepinone derivatives and cholecystokinin antagonist pharmaceutical compositions containing them
TWI288747B (en) Calcium salts of a 1,5-benzodiazepine derivative, a process for preparing the same, and drugs containing the same as the active ingredient
US7342007B2 (en) Lactams and uses thereof
AU688316B2 (en) 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
CN117480161A (zh) 作为σ配体的新型2,3-二氢-1H-吡咯并[3,2-b]吡啶衍生物
Sayago et al. Versatile methodology for the synthesis and α-functionalization of (2R, 3aS, 7aS)-octahydroindole-2-carboxylic acid